Nuvo Pharmaceuticals Inc (MRV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 27,039 | 21,352 | 13,057 | 18,409 | 24,650 |
| Cost of Goods | 11,357 | 10,276 | 5,537 | 4,769 | 7,275 |
| Gross Profit | 15,682 | 11,076 | 7,520 | 13,640 | 17,375 |
| Operating Expenses | 8,094 | 19,624 | 21,029 | 17,143 | 20,864 |
| Operating Income | 7,588 | -8,548 | -13,509 | -3,503 | -3,489 |
| Interest Expense | N/A | 40 | 713 | 649 | 381 |
| Other Income | -179 | 1,475 | 52,831 | -6,109 | -9,497 |
| Pre-tax Income | 7,409 | -7,113 | 38,609 | -10,261 | -13,367 |
| Income Tax | 0 | 7 | 19 | 117 | 196 |
| Net Income Continuous | 7,409 | -7,120 | 38,590 | -10,378 | -13,563 |
| Net Income Discontinuous | -3,180 | N/A | N/A | N/A | N/A |
| Net Income | $4,229 | $-7,120 | $38,590 | $-10,378 | $-13,563 |
| EPS Basic Total Ops | 0.37 | -0.65 | 3.85 | -1.18 | -1.56 |
| EPS Basic Continuous Ops | 0.65 | -0.65 | 3.85 | -1.18 | -1.56 |
| EPS Basic Discontinuous Ops | -0.28 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.36 | -0.65 | 3.76 | -1.18 | -1.56 |
| EPS Diluted Continuous Ops | 0.63 | -0.65 | 3.76 | -1.18 | -1.56 |
| EPS Diluted Discontinuous Ops | -0.28 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA(a) | $7,821 | $-6,760 | $40,037 | $-8,274 | $-12,312 |